Eleftha 375 mg Injection 1's

Question 1

How does Eleftha 375 mg Injection 1's work?

Accepted Answer

Eleftha 375 mg Injection 1's contains Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.

Question 2

What are the points to be informed to the doctor before starting treatment?

Accepted Answer

Inform your doctor whether you have received any other cancer treatment. Eleftha 375 mg Injection 1's may cause a decrease in left ventricular ejection fraction, cardiomyopathy, hypersensitivity reactions, pulmonary toxicity, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Eleftha 375 mg Injection 1's.

Welcome User

Eleftha 375 mg Injection 1's

Vivitra 375 mg Injection 1's